Lip Injection Market Forecast Shows US$ 7.8 Billion Opportunity by 2034 at 7.4% CAGR

Trishita Deb
Trishita Deb

Updated · Aug 5, 2026

SHARE:

Market.us Media, we strive to bring you the most accurate and up-to-date information by utilizing a variety of resources, including paid and free sources, primary research, and phone interviews. Learn more.
close
Advertiser Disclosure

At Market.us Media, we strive to bring you the most accurate and up-to-date information by utilizing a variety of resources, including paid and free sources, primary research, and phone interviews. Our data is available to the public free of charge, and we encourage you to use it to inform your personal or business decisions. If you choose to republish our data on your own website, we simply ask that you provide a proper citation or link back to the respective page on Market.us Media. We appreciate your support and look forward to continuing to provide valuable insights for our audience.

Overview

New York, NY – Aug 05, 2026 – The Global Lip Injection Market size is expected to be worth around US$ 7.8 Billion by 2034 from US$ 3.8 Billion in 2024, growing at a CAGR of 7.4% during the forecast period 2025 to 2034. In 2024, North America led the market, achieving over 42.2% share with a revenue of US$ 1.6 Billion.

The global Lip Injection Market is witnessing strong growth, driven by increasing consumer interest in minimally invasive aesthetic procedures and rising awareness of facial enhancement treatments. Lip injections have become one of the most popular non-surgical cosmetic procedures due to their ability to provide immediate, natural-looking results with minimal recovery time. The growing influence of social media, beauty trends, and the increasing preference for facial symmetry continue to encourage demand across different age groups.

According to the American Society of Plastic Surgeons (ASPS), nearly 1.4 million lip augmentation procedures using injectable materials were performed in 2024, highlighting the widespread acceptance of cosmetic injectables. Hyaluronic acid (HA)-based fillers remain the leading product category because of their excellent safety profile, natural appearance, and reversibility. The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) also reports that approximately 90% of facial plastic surgeons routinely provide injectable fillers and neurotoxins, demonstrating the extensive availability of these treatments.

Manufacturers are focusing on advanced filler formulations that improve flexibility, durability, and patient comfort while extending treatment longevity. Strategic partnerships and acquisitions are further strengthening product portfolios and expanding global market reach. For instance, Prollenium Medical Technologies’ acquisition of SoftFil in 2022 enhanced innovation in injection devices and filler delivery systems.

Growing consumer spending on aesthetic treatments, increasing numbers of certified practitioners, and continuous technological advancements are expected to support sustained market expansion. With rising demand for personalized, safe, and effective cosmetic procedures, the Lip Injection Market is expected to maintain positive growth momentum throughout the forecast period.
Lip Injection Market Size

Key Takeaways

  • The global lip injection market was valued at US$ 3.8 billion in 2024 and is projected to reach US$ 7.8 billion by 2034, expanding at a CAGR of 7.4% during the forecast period.
  • By product type, the market is segmented into hyaluronic acid fillers, collagen fillers, calcium hydroxyapatite fillers, poly-L-lactic acid fillers, and others. Among these, hyaluronic acid fillers dominated the market with a 50.2% share in 2023.
  • Based on type, the market is categorized into temporary and permanent lip injections. The temporary segment accounted for the largest share, representing 72.1% of the market.
  • By application, the market is divided into cosmetic enhancement and reconstructive procedures. The cosmetic enhancement segment led the market, capturing 62.5% of the total revenue share.
  • Based on the distribution channel, the market is segmented into drug pharmacy & retail and online. The drug pharmacy & retail segment held the leading position with a 51.1% market share.
  • By end user, the market includes specialty & dermatology clinics, hospitals & clinics, beauty salons/spa centers, and others. Specialty & dermatology clinics emerged as the dominant segment, accounting for 40.3% of the market revenue.
  • North America was the leading regional market, accounting for a 42.2% share of the global lip injection market in 2023

Statistical Information

  • Rising Demand for Lip Augmentation Procedures: The demand for lip injections continues to increase as more consumers choose minimally invasive cosmetic procedures. According to the American Society of Plastic Surgeons (ASPS), 1,449,565 lip augmentation procedures using injectable materials were performed in 2024, representing a 1% increase from 2023 (1,439,291 procedures). This demonstrates sustained consumer demand for lip enhancement treatments.
  • Hyaluronic Acid (HA) Fillers Dominate Injectable Treatments: Hyaluronic acid fillers remain the preferred injectable product because of their safety profile and natural-looking results. ASPS reported 5,331,426 hyaluronic acid filler procedures in 2024, compared with 932,861 non-HA filler procedures, showing that HA fillers account for the overwhelming majority of dermal filler treatments.
  • Strong Consumer Preference for Minimally Invasive Cosmetic Procedures: Consumers increasingly prefer non-surgical aesthetic treatments that require little recovery time. ASPS reported more than 28.2 million minimally invasive cosmetic procedures in 2024, compared with approximately 1.6 million cosmetic surgical procedures, highlighting the significant shift toward minimally invasive treatments such as fillers.
  • Injectable Fillers Are Widely Offered by Facial Plastic Surgeons: The availability of injectable treatments continues to expand across aesthetic clinics. According to the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) 2024 Annual Trends Survey, 90% of facial plastic surgeons regularly perform dermal filler and neurotoxin injections, indicating broad access to these procedures throughout North America.
  • Injectable Treatments Represent the Majority of Facial Aesthetic Procedures: AAFPRS reports that non-surgical treatments account for approximately 80% of all facial aesthetic procedures performed by its members. This reflects growing patient preference for procedures that provide quick results with minimal downtime compared to traditional surgery.
  • Lip Enhancement Remains One of the Most Common Facial Procedures: The International Society of Aesthetic Plastic Surgery (ISAPS) reported 108,373 lip enhancement/perioral procedures performed in the United States during 2024. The survey also recorded 1,229,041 hyaluronic acid injectable procedures, confirming strong consumer demand for injectable facial enhancements.
  • Consumer Demand Continues Despite Economic Uncertainty: ASPS found that demand for cosmetic treatments remained resilient during 2024. More than 28.5 million minimally invasive procedures were completed, demonstrating that consumers continue investing in aesthetic enhancements even during periods of economic uncertainty.
  • Growing Focus on Patient Safety and Qualified Providers: Government and professional organizations continue emphasizing treatment safety. The U.S. FDA and American Society of Plastic Surgeons (ASPS) warn consumers against purchasing or self-injecting dermal fillers because counterfeit or improperly administered products can cause vascular occlusion, infection, tissue damage, and permanent disfigurement. This has increased consumer preference for licensed providers.

Regional Analysis

North America led the market by securing a market share of 42.2% in 2023.

North America dominated the global lip injection market in 2024, accounting for 42.2% of total revenue. The region benefits from advanced aesthetic healthcare infrastructure, strong consumer awareness, and high demand for minimally invasive cosmetic procedures. The United States remains the largest contributor, supported by widespread availability of board-certified practitioners and continued regulatory approvals for hyaluronic acid-based dermal fillers.

According to the American Society of Plastic Surgeons (ASPS), more than 1.4 million soft tissue filler procedures were performed in 2023, reflecting sustained consumer interest in facial aesthetic enhancements. The US Food and Drug Administration (FDA) continues to approve innovative filler products, improving treatment safety and patient confidence.

Asia Pacific is projected to register the fastest CAGR during the forecast period. Rising disposable incomes, expanding medical aesthetics clinics, and growing social media influence are driving demand across China, South Korea, Japan, and India. According to the International Society of Aesthetic Plastic Surgery (ISAPS), China ranks among the world’s leading countries for aesthetic procedures, while South Korea continues to lead in cosmetic innovation and practitioner expertise, supporting strong regional market expansion.

  • Growing demand for hyaluronic acid (HA) fillers: Hyaluronic acid fillers remain the preferred choice because they provide natural-looking results and can be dissolved if needed. ISAPS reported 6.3 million hyaluronic acid filler procedures globally in 2024, a 5.2% increase from the previous year, showing continued consumer preference for minimally invasive treatments.
  • Rising popularity of lip enhancement procedures: Lip enhancement is becoming one of the fastest-growing facial aesthetic treatments. According to ISAPS, lip enhancement/perioral procedures reached about 0.9 million globally in 2023, representing a 29% annual increase, driven by younger consumers seeking subtle facial enhancement.
  • Innovation through FDA-approved dermal fillers: Manufacturers are introducing advanced fillers with improved durability and safety. The U.S. FDA has approved several lip-specific dermal fillers, including products for lip augmentation and perioral lines, helping physicians deliver more personalized treatments with validated clinical safety and effectiveness.
  • Increasing preference for minimally invasive aesthetics: Patients increasingly prefer injectable treatments because they require little recovery time and provide immediate visible results. ASPS reported that minimally invasive injectable procedures continued to grow in 2024, with injectables increasing 1.5%, while lip augmentation remained among the top five minimally invasive cosmetic procedures.
  • Expansion of male aesthetic procedures: More men are choosing cosmetic injectables, expanding the customer base for lip fillers. The American Academy of Dermatology, citing ASPS data, reported that over 1.4 million men underwent minimally invasive cosmetic procedures, with dermal filler treatments increasing 70% since 2019 among male patients.

Use Cases

  • Lip volume enhancement: Lip injections are widely used to increase lip fullness while maintaining a natural appearance. FDA-approved hyaluronic acid fillers are specifically indicated for lip augmentation in adults, providing temporary volume enhancement with clinically evaluated safety and effectiveness.
  • Correction of age-related volume loss: As people age, lips lose volume and definition. Injectable fillers help restore lost tissue, improve lip contours, and reduce wrinkles around the mouth. FDA-approved fillers are commonly used to treat upper perioral lines while preserving facial harmony.
  • Correction of lip asymmetry: Cosmetic specialists use lip injections to balance uneven lip shapes caused by genetics, aging, or previous injuries. Customized filler placement improves symmetry and facial proportions without requiring surgical procedures, making it a popular outpatient aesthetic treatment.
  • Combination facial rejuvenation treatments: Lip injections are increasingly combined with botulinum toxin, cheek fillers, and skin rejuvenation procedures to provide comprehensive facial enhancement. ISAPS reported over 20.5 million non-surgical aesthetic procedures worldwide in 2024, reflecting growing adoption of combination treatment plans.
  • Preventive aesthetic treatments among younger adults: Younger consumers are increasingly using lip fillers for early aesthetic enhancement and facial contouring rather than age correction. ISAPS data show that facial aesthetic procedures continue to rise globally, with strong growth in non-surgical facial treatments among adults seeking preventive cosmetic care.

Frequently Asked Questions on Lip Injection

  • Are lip injections safe?
    Lip injections are generally safe when performed by a qualified medical professional using FDA-approved dermal fillers. Temporary swelling, bruising, and redness are common, while serious complications are uncommon when proper injection techniques and approved products are used.
  • How long do lip injection results last?
    Most lip fillers provide visible results for about 6 to 12 months. Longevity depends on the filler type, metabolism, injection technique, and individual lifestyle. Periodic maintenance treatments are usually recommended to maintain the desired appearance.
  • Who is a suitable candidate for lip injections?
    Healthy adults seeking fuller lips, improved lip symmetry, or correction of age-related volume loss are suitable candidates. A professional consultation helps determine the appropriate treatment based on facial structure, medical history, and aesthetic goals.
  • What should patients expect after the procedure?
    Mild swelling, tenderness, and bruising may occur for one to three days after treatment. Most individuals return to normal activities immediately, although strenuous exercise and excessive heat exposure should be avoided for the first 24–48 hours.
  • What is driving the growth of the Lip Injection Market?
    Market growth is supported by increasing demand for minimally invasive cosmetic procedures, growing beauty awareness, rising disposable income, expanding social media influence, and continuous innovation in safer, longer-lasting dermal filler products.
  • Which product segment dominates the Lip Injection Market?
    Hyaluronic acid fillers dominate the market because they offer natural-looking results, reversible treatment, excellent safety profiles, and minimal downtime. Their widespread regulatory approvals and high patient satisfaction continue to support strong global demand.
  • Which region leads the Lip Injection Market?
    North America leads the global market due to advanced healthcare infrastructure, high consumer awareness, greater spending on cosmetic treatments, and widespread availability of experienced aesthetic practitioners and FDA-approved injectable products.
  • What are the future opportunities in the Lip Injection Market?
    Future opportunities include development of longer-lasting fillers, personalized treatment approaches, increased adoption among male consumers, expansion into emerging markets, and technological advances that improve injection precision, safety, and patient satisfaction.

Conclusion

The global lip injection market is expected to witness steady growth due to rising demand for minimally invasive cosmetic procedures, increasing awareness of facial aesthetics, and continuous advancements in dermal filler technologies. Hyaluronic acid fillers remain the preferred choice because of their safety, effectiveness, and natural-looking results.

North America continues to lead the market with strong consumer demand and advanced healthcare infrastructure, while Asia Pacific is emerging as the fastest-growing region due to increasing disposable incomes and expanding aesthetic clinics. Ongoing product innovation, growing acceptance among diverse consumer groups, and improved practitioner expertise are expected to create significant growth opportunities throughout the forecast period.

Discuss your needs with our analyst

Please share your requirements with more details so our analyst can check if they can solve your problem(s)

SHARE:
Trishita Deb

Trishita Deb

Trishita has more than 8+ years of experience in market research and consulting industry. She has worked in various domains including healthcare, consumer goods, and materials. Her expertise lies majorly in healthcare and has worked on more than 400 healthcare reports throughout her career.

Latest from the featured industries
Request a Sample Report
We'll get back to you as quickly as possible